皮皮学,免费搜题
登录
搜题
【单选题】
Scientists are hoping to eliminate malaria (疟疾) by developing a genetically modified mosquito that cannot transmit the disease. Malaria has long troubled the populations of South America, Africa, and Asia, where mosquito bites infect up to 500 million people a year with this serious and sometimes fatal parasitic blood disease. For generations, scientists have been trying to eliminate malaria by developing new drugs and using pesticides (杀虫剂) to wipe out local mosquito populations. But these measure aren't working--and some scientists, like Greg Lanzaro, say that because of drug resistance and population changes, malaria is actually more prevalent now than it was 20 years ago. Lanzaro says he has a better way to stop the spread of malaria: genetically modifying mosquitoes so they are unable to carry the disease. Lanzaro and his. colleagues are planning a multi-year project to produce malaria-resistant mosquitoes--and he thinks they can do it within five years. 'We can get foreign genes into mosquitoes and they go where they're supposed to go,' Lanzaro says, pointing out that scientists have already succeeded in genetically engineering mosquitoes that cannot transmit malaria to birds and mice. And, he says, scientists are quickly making progress on genes that block transmission of the disease to humans as well. The most difficult part scientifically, Lanzaro says, is figuring out how to get the lab-engineered mosquitoes to spread their genes into natural populations. After all, he points out, it's useless to engineer mosquitoes in the lab that can't transmit malaria when there are millions out in the wild that can. To solve this problem, Lanzaro wants to load up a mobile piece of DNA with the malaria-resistant gene, and then insert it into a group of mosquito embryos. The malaria-resistant gene would be integrated directly into the mosquitoes' DNA, making it impossible for those mosquitoes to transmit the parasite that causes malaria. In this way a small group of lab-raised mosquitoes could be released into the wild, and by interbreeding with wild mosquitoes, eventually transmit the beneficial gene to the entire population. One reason for malaria to be widespread now is that ______
A.
more people have moved to malaria-infected areas
B.
mosquitoes have become resistant to pesticides
C.
genetically modified mosquitoes still transmit the disease
D.
mosquitoes bite as many as 500 million people a year
拍照语音搜题,微信中搜索"皮皮学"使用
参考答案:
参考解析:
知识点:
.
..
皮皮学刷刷变学霸
举一反三
【单选题】最易出现脾脏高度肿大的白血病是
A.
急性单核细胞白血病
B.
急性粒细胞白血病
C.
慢性粒细胞白血病
D.
急性淋巴细胞白血病
E.
慢性淋巴细胞白血病
【单选题】免疫应答的过程包括
A.
免疫细胞对抗原分子的识别过程
B.
免疫细胞的活化过程
C.
免疫细胞的分化过程
D.
免疫效应细胞和效应分子发挥效应
E.
以上全都对
【单选题】在变动成本法下,对本期固定性制造费用的处理应是( )
A.
售出部分转化为销货成本,计入损益表
B.
全额从本期销售收入中扣除
C.
未销售部分与售出部分均作为存货成本,计入资产负债表
D.
未售部分转为存货成本,计入资产负债表
【单选题】最易出现脾脏高度肿大的白血病是
A.
急性粒细胞性白血病
B.
慢性粒细胞性白血病
C.
急性淋巴细胞性白血病
D.
慢性淋巴细胞性白血病
E.
急性单核细胞性白血病
【单选题】在变动成本法下,对本期固定性制造费用处理应是( )
A.
售出部分转为销货成本,计入损益表
B.
全额从本期销售收入中扣除
C.
未售出部分与售出部分均作为存货成本,计入资产负债表
D.
未售出部分转为存货成本,计入资产负债表
【单选题】在变动成本法下,对本期固定性制造费用处理应是( )
A.
售出部分转为销货成本,计人损益表
B.
全额从本期销售收入中扣除
C.
未售出部分与售出部分均作为存货成本,计入资产负债表
D.
未售出部分转为存货成本,计入资产负债表
【单选题】在变动成本法下,对本期固定性制造费用处理应是( )
A.
售出部分转为销货成本,计入损益表
B.
全额从本期销售收入中扣除
C.
未售出与出售部分均作为存货成本,计入资产负责表
D.
未售出部分转为存货成本,计入资产负债表
【多选题】以下哪些情况属于严重心理问题?
A.
负面情绪持续大于2个月,间断小于6个月
B.
负面情绪持续小于1个月,间断小于2个月
C.
社会功能没有明显受损,工作效率下降,不失控
D.
较强烈现实问题,强烈的道德冲突
【多选题】免疫应答的过程包括
A.
抗原识别阶段
B.
免疫细胞的活化和分化阶段
C.
免疫细胞的膜攻击阶段
D.
免疫应答的效应阶段
E.
免疫记忆形成阶段
【单选题】能用于阿片、吗啡、海洛因成瘾者脱毒治疗的药物是
A.
曲马多
B.
罗通定
C.
布桂嗪
D.
美沙酮
相关题目: